IE 11 is not supported. For an optimal experience visit our site on another browser.

Moderna announces new vaccine is 94.5 percent effective


Moderna says that their preliminary trial data shows that their vaccine candidate is 94.5% effective. Moderna's Chief Medical Officer, Dr. Tal Zaks, describes how the mRNA-1273 vaccine induces high levels of neutralizing antibodies which help the body fight off the virus.